Table 1.
Ref. |
Correlation |
Direction of correlation | P | |
Physiological parameter | DCE-MRI measurement | |||
Buadu et al[76], 1996 | MVD | Amplitude | + | < 0.01 |
Slope maximum | + | < 0.01 | ||
Enhancement Maximum time | - | < 0.01 | ||
Tumor size | .. | NS | ||
Stomper et al[77], 1996 | DNA S-phase percentage | Signal enhancement amplitude | .. | NS |
Signal enhancement rate | .. | NS | ||
Signal washout | .. | NS | ||
Hulka et al[78], 1997 | Tumor grade | RSI | + | < 0.01 |
Matsubayashi et al[79], 2000 | Peripheral-central MVD ratio | Early rim enhancement | + | 0.048 |
Peripheral-central fibrosis ratio | Early rim enhancement | - | < 0.01 | |
Central-peripheral fibrosis ratio | Delayed rim | + | 0.013 | |
Gianfelice et al[80], 2003 | Residue tumor percentage after MRIgFUS | ISI | + | NR |
MDF | + | NR | ||
PEI | + | NR | ||
Su et al[81], 2003 | VEGF | Apparent Vb | .. | NS |
In-flux rate and distribution volume in interstitial space (VeK1) | .. | NS | ||
Out-flux rate (K2) | .. | NS |
NS: Not significant; NR: Not reported; RSI: Relative signal intensity; MVD: Microvessel density; ISI: Increase in signal intensity; MDF: Maximum difference function; PEI: Positive enhancement interal; Vb: Vascular volume; VEGF: Vascular endothelial growth factor.